April 6th, 2011
Large Study Finds Wide Differences in Risks Among Diabetes Drugs
Larry Husten, PHD
A very large observational study has found an increase in death and cardiovascular risk in people taking insulin secretagogues (ISs) compared with those taking metformin. Tina Ken Schramm and colleagues, reporting in the European Heart Journal, analyzed data from the entire population of Denmark and identified 107,806 people who initiated therapy with an IS or […]
NEJM Journal Watch — Recent Cardiology Articles- Cardiovascular Outcomes of Tirzepatide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long Is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction